Efficacy and Safety of the 64Cu(II)Cl2 PET/CT for Urological Malignancies-Reference-Cited by-同舟云学术

Efficacy and Safety of the 64Cu(II)Cl2 PET/CT for Urological Malignancies

Published:2021-04-21 Issue:6 Volume:46 Page:443-448
ISSN:1536-0229
Container-title:Clinical Nuclear Medicine
language:en
Short-container-title:Clin Nucl Med

Author:

Mascia Manlio,Villano Carlo,De Francesco Valerio,Schips Luigi,Marchioni Michele,Cindolo Luca

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference16 articles.

1. Metal complexes, their cellular targets and potential for cancer therapy;Curr Pharm Des,2009

2. Role of copper in tumour angiogenesis—clinical implications;J Trace Elem Med Biol,2004

3. Behind the link between copper and angiogenesis: established mechanisms and an overview on the role of vascular copper transport systems;J Vasc Res,2015

4. Targeting copper in cancer therapy: ‘copper that cancer’;Metallomics,2015

5. Positron emission tomography of altered copper metabolism for metabolic imaging and personalized therapy of prostate cancer;J Radiol Radiat Ther,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surveillance or Dynamic Sentinel Lymph-Node Biopsy in Low-Risk Clinically N0 Penile Squamous Cell Carcinoma: Single-Institution Real World Data;Clinical Genitourinary Cancer;2024-01

2. 68Ga-PSMA-11 PET/CT and 64CuCl2 PET/CT Help in Identifying Rare Metastatic Site of Penile Shaft in a Patient of Carcinoma Prostate;Clinical Nuclear Medicine;2023-11-16

3. Copper in Cancer: from transition metal to potential target;Human Cell;2023-09-26

4. Targeting Copper in Cancer Imaging and Therapy: A New Theragnostic Agent;Journal of Clinical Medicine;2022-12-28

5. Synergism of ⁶⁴Cu-Labeled RGD with Anti-PD-L1 Immunotherapy for the Long-Acting Antitumor Effect;Bioconjugate Chemistry;2022-10-18